Microbiotica Announces Clinical Trial Collaboration with MSD

Microbiotica, a leader in discovering and developing microbiome-based therapeutics and biomarkers, today announces it has entered into a clinical trial collaboration with MSD (Merck Co., Inc., Rahway

Related Keywords

United States , Chesterford , Essex , United Kingdom , Cambridge , Cambridgeshire , British , Ro Gardner , Tim Sharpington , Sanger Institute , Ip Group , Chesterford Research Park , Twitter , Merck Sharp Dohme , Merck Co Inc , Linkedin , Personalised Bacterial Bank , Cytotoxict Lymphocyte , Reference Genome Database , Culture Collection , British Patient Capital , Cambridge Innovation Capital , Flerie Invest , Seventure Partners , Microbiotica , Nnounces , Linical , Trial , Collaboration , Valuate , B097 , Combination , Keytruda , Pembrolizumab , Hase , Melanoma ,